当前位置: 首页 > 期刊 > 《中国现代医生》 > 2019年第12期
编号:13381565
AMPK抑制TGF-β信号通路减轻EMT诱导膀胱癌转移机制研究(5)
http://www.100md.com 2019年4月25日 《中国现代医生》 2019年第12期
     [15] Sisto M,Lisi S,Ribatti D. The role of the epithelial-to-mesenchymal transition(EMT)in diseases of the salivary glands[J]. Histochem Cell Biol,2018,23(1):12-16.

    [16] Qu C,Zhang W,Zheng G,et al. Metformin reverses multidrug resistance and epithelial-mesenchymal transition(EMT)via activating AMP-activated protein kinase(AMPK)in human breast cancer cells[J]. Mol Cell Biochem,2014, 386(1-2):63-71.

    [17] Han B,Cui H,Kang L,et al. Metformin inhibits thyroid cancer cell growth,migration,and EMT through the mTOR pathway[J]. Tumour Biol,2015,36(8):6295-6304.

    [18] Pal M,Bhattacharya S,Kalyan G,et al. Cadherin profiling for therapeutic interventions in Epithelial Mesenchymal Transition(EMT)and tumorigenesis[J]. Exp Cell Res,2018,368(2):137-146.

    [19] Yoshida T,Ozawa Y,Kimura T,et al. Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial-mesenchymal transition(EMT) to mesenchymal-epithelial transition(MET)states[J]. Br J Cancer,2014,110(6):1497-1505.

    [20] Bays JL,Campbell HK,Heidema C,et al. Linking E-cadherin mechanotransduction to cell metabolism through force-mediated activation of AMPK[J]. Nat Cell Biol,2017, 19(6):724-731.

    (收稿日期:2018-07-11), http://www.100md.com(孔晓武 丁青 张琦)
上一页1 2 3 4 5